• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《中国普通人群胃癌风险管理指南(2023年版)》

[Chinese Guideline on Risk Management of Gastric Cancer in the General Public(2023 Edition)].

出版信息

Zhonghua Yi Xue Za Zhi. 2023 Sep 26;103(36):2837-2849. doi: 10.3760/cma.j.cn112137-20230608-00968.

DOI:10.3760/cma.j.cn112137-20230608-00968
PMID:37726990
Abstract

The disease burden of gastric cancer is considerable heavy in China, where the annual number of new gastric cancer cases and deaths rank first in the world. It has been shown that risk assessment, screening, and reducing risk factors may effectively reduce gastric cancer development in general population. However, there is currently a lack of practice guidelines on risk management of gastric cancer for the general public in China. This guideline was conducted by the Chinese Gastric Cancer Association (CGCA) and Chinese Society of Upper Gastrointestinal Surgeons (CSUGS). Based on the best research evidence and health expertise, we developed 17 questions and formulated 18 recommendations. These recommendations provide comprehensive guidance for the management of gastric cancer risk in the general public, with the potential to reduce the cancer development and the burden of disease.

摘要

在中国,胃癌的疾病负担相当沉重,每年新增胃癌病例数和死亡数均位居世界首位。研究表明,风险评估、筛查以及降低风险因素可有效减少普通人群中胃癌的发生。然而,目前中国缺乏针对普通公众的胃癌风险管理实践指南。本指南由中国胃癌协会(CGCA)和中国上消化道外科医师学会(CSUGS)制定。基于最佳研究证据和健康专业知识,我们提出了17个问题并制定了18条建议。这些建议为普通公众的胃癌风险管控提供了全面指导,有望减少癌症发生和疾病负担。

相似文献

1
[Chinese Guideline on Risk Management of Gastric Cancer in the General Public(2023 Edition)].《中国普通人群胃癌风险管理指南(2023年版)》
Zhonghua Yi Xue Za Zhi. 2023 Sep 26;103(36):2837-2849. doi: 10.3760/cma.j.cn112137-20230608-00968.
2
[Clinical practice guideline for appropriate use of gastric acid suppressants in gastrointestinal surgery (2022 edition)].[《胃肠外科手术中胃酸抑制剂合理使用临床实践指南(2022年版)》]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Nov 25;25(11):933-946. doi: 10.3760/cma.j.cn441530-20221024-00429.
3
[Systematic review of methodological quality and reporting quality in gastric cancer screening guidelines].[胃癌筛查指南的方法学质量和报告质量的系统评价]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 6;54(3):314-319. doi: 10.3760/cma.j.issn.0253-9624.2020.03.013.
4
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer.中国临床肿瘤学会(CSCO):胃癌诊断与治疗临床实践指南。
Cancer Commun (Lond). 2019 Mar 18;39(1):10. doi: 10.1186/s40880-019-0349-9.
5
[Quality assessment of guidelines on upper gastrointestinal cancer screening].[上消化道癌筛查指南的质量评估]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jul 10;42(7):1318-1324. doi: 10.3760/cma.j.cn112338-20200805-01023.
6
Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.可切除胃癌的新辅助或辅助治疗:北美系统评价和实践指南。
Gastric Cancer. 2013 Jan;16(1):28-40. doi: 10.1007/s10120-012-0148-3. Epub 2012 Mar 31.
7
[Chinese expert consensus on the diagnosis and treatment of peritoneal metastasis of gastric cancer (2023 edition)].《中国胃癌腹膜转移诊断与治疗专家共识(2023年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Aug 25;26(8):717-728. doi: 10.3760/cma.j.cn441530-20230608-00196.
8
[China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing)].《中国胃癌筛查与早诊早治指南(2022年,北京)》
Zhonghua Zhong Liu Za Zhi. 2022 Jul 23;44(7):634-666. doi: 10.3760/cma.j.cn112152-20220617-00430.
9
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.胃癌的诊断和治疗:第 12 届 ESMO/世界胃肠癌大会专家讨论和建议,巴塞罗那,2010 年。
Ann Oncol. 2011 Jun;22 Suppl 5:v1-9. doi: 10.1093/annonc/mdr284.
10
Clinical management of gastric cancer: results of a multicentre survey.胃癌的临床管理:多中心调查结果。
BMC Cancer. 2011 Aug 24;11:369. doi: 10.1186/1471-2407-11-369.

引用本文的文献

1
Transforming Growth Factor Beta2 Promotes Migration and Inhibits the Proliferation of Gastric Cancer Cells by Regulating the pSmad2/3-NDRG1 Signaling Pathway.转化生长因子β2通过调节pSmad2/3-NDRG1信号通路促进胃癌细胞迁移并抑制其增殖。
MedComm (2020). 2025 Mar 27;6(4):e70148. doi: 10.1002/mco2.70148. eCollection 2025 Apr.
2
Factors influencing the incidence of early gastric cancer: a bayesian network analysis.影响早期胃癌发病率的因素:贝叶斯网络分析
BMC Gastroenterol. 2025 Mar 21;25(1):194. doi: 10.1186/s12876-025-03765-7.
3
Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China.
中国晚期或转移性胃/胃食管交界腺癌的治疗模式与结局
Future Oncol. 2025 Apr;21(10):1179-1188. doi: 10.1080/14796694.2025.2476930. Epub 2025 Mar 17.
4
Cost-effectiveness of open vs. laparoscopic gastrectomy for locally advanced gastric cancer in China.中国开放性与腹腔镜胃癌根治术治疗局部进展期胃癌的成本效益分析
Sci Rep. 2025 Feb 25;15(1):6714. doi: 10.1038/s41598-025-91003-1.
5
Research Status of the Knowledge-Attitude-Practice Theory Model in Gastric Cancer Prevention.知信行理论模型在胃癌预防中的研究现状
Cureus. 2024 Jul 19;16(7):e64960. doi: 10.7759/cureus.64960. eCollection 2024 Jul.